Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 ballot International flag

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

Example Group: Adults with type 2 diabetes and established CVD (but no CKD)

version: 68; Last updated: 2026-01-29 20:43:49+0000; Language: en

Artifact Author: Computable Publishing®: MAGIC-to-FEvIR Converter:

Artifact related artifact: No display for RelatedArtifact (type: part-of; resourceReference: ->display: string (PrimitiveType/Group.extension[1].value[x].resourceReference.display): element = string -> display=string[MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes])

CiteAs:

Adults with type 2 diabetes and established CVD (but no CKD) [Database Entry: FHIR Group Resource]. Contributors: Computable Publishing®: MAGIC-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 236533. Revised 2026-01-29. Available at: https://fevir.net/resources/Group/236533. Computable resource at: https://fevir.net/resources/Group/236533#json.

url: https://fevir.net/resources/Group/236533

identifier: FEvIR Object Identifier/236533, FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-population-group-85390-85789

name: Adults_with_type_2_diabetes_with_moderate_CV_risk

title: Adults with type 2 diabetes and established CVD (but no CKD)

status: Active

publisher: Computable Publishing LLC

contact: support@computablepublishing.com

description:

This Group Resource is referenced in an example for the EBMonFHIR Implementation Guide.

copyright:

https://creativecommons.org/licenses/by-nc-sa/4.0/

membership: Conceptual